The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Open accessAbstract
Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of auto-ubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappaB signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappaB pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This switch between target substrate ubiquitylation and autoubiquitylation following changes in binding partner might be a general feature of RING E3 ligases, since ligand binding to IAP (a member of the RING E3 inhibitor of apoptosis proteins) stimulates IAP auto-destruction [43].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [43]
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., HAVEMAN, J., & Chris van, B. R. E. E. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,202
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I. I., Oliver, H., Lutter, M. L., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,577
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,469
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
TNF-R1 Signaling: A Beautiful Pathway
Chen, G., & Goeddel, D. V. (2002) · Science · doi:10.1126/science.1071924 · Cited by 1,930
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
How adhesion signals reach a mitochondrial conclusion — ECM regulation of apoptosis
Gilmore, A. P., Owens, T. W., Foster, F. M., & Lindsay, J. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.05.009 · Cited by 48
Choi, J., Bogenberger, J. M., & Tibes, R. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00711-3 · Cited by 45
Álvarez-Díaz, S., Preaudet, A., Samson, A. L., Nguyen, P. M., Fung, K. Y., Garnham, A. L., Alexander, W. S., Strasser, A., Ernst, M., Putoczki, T. L., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00673-z · Cited by 47
Dean, E. J., Ward, T. H., Pinilla, C., Houghten, R. A., Welsh, K., Makin, G., Ranson, M., & Dive, C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605418 · Cited by 46
TRAF-mediated regulation of immune and inflammatory responses
Wang, Y., Zhang, P., Liu, Y., & Cheng, G. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0050-3 · Cited by 46
Flanagan, L., Kehoe, J., Fay, J., Bacon, O., Lindner, A. U., Kay, E. W., Deasy, J., McNamara, D. A., & Prehn, J. H. M. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0437-1 · Cited by 45
Hepatocellular carcinoma and the ubiquitin–proteasome system
Dawson, S. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.003 · Cited by 45
Apoptosis in schistosomes: toward novel targets for the treatment of schistosomiasis
Lee, E. F., Young, N. D., Lim, N. T. Y., Gasser, R. B., & Fairlie, W. D. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2013.12.005 · Cited by 45
Petrucci, E., Pasquini, L., Bernabei, M., Saulle, E., Biffoni, M., Accarpio, F., Sibio, S., Giorgio, A. D., Donato, V. D., Casorelli, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035073 · Cited by 45
E3 ubiquitin ligases in ErbB receptor quantity control
Carraway, K. L. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.09.006 · Cited by 47
Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity
Döppler, H. R., Liou, G., & Störz, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053676 · Cited by 45
Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis
Eckhardt, I., Roesler, S., & Fulda, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.457 · Cited by 45
“This might be mediated through crosstalk between the two NF-kB signaling branches: NIK, a well-described mediator of non-canonical NF-kB signaling, accumulates upon cIAP1/2 depletion by BV6 and initiates p100 processing.(12,13) NIK is known to activate IKKa and can mediate crosstalk between the non-canonical and canon…”
InfluentialEschenburg, G., Eggert, A., Schramm, A. R., Lode, H. N., & Hundsdoerfer, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4072 · Cited by 46
Koschel, J., Nishanth, G., Just, S., Harit, K., Kröger, A., Deckert, M., Naumann, M., & Schlüter, D. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00752-9 · Cited by 43
Dupoux, A., Cartier, J., Cathelin, S., Filomenko, R., Solary, É., & Dubrez, L. (2008) · Blood · doi:10.1182/blood-2008-02-137919 · Cited by 45
cIAP1-based degraders induce degradation via branched ubiquitin architectures
Akizuki, Y., Morita, M., Mori, Y., Kaiho-Soma, A., Dixit, S., Endo, A., Shimogawa, M., Hayashi, G., Naito, M., Okamoto, A., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01178-1 · Cited by 46
Boutaffala, L., Bertrand, M. J. M., Remouchamps, C., Seleznik, G. M., Reisinger, F., Janas, M. K., Bénézech, C., Fernandes, M. T., Marchetti, S., Mair, F., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.69 · Cited by 45
“As previously reported, degradation of c-IAP-1/2 is critical for Tweak/TNFα- or SM/TNFα-induced cell death.(26,28,33) Yet, we observed that the level of Tweak-, agonist LTβR- or CmpAinduced c-IAP1/2 degradation was similar in NIK and NIK /− MEFs, indicating that c-IAP1/2 depletion is not compromised in the absence of…”
Pellino3 targets RIP1 and regulates the pro-apoptotic effects of TNF-α
Yang, S., Wang, B., Tang, L. S., Siednienko, J., Callanan, J. J., & Moynagh, P. N. (2013) · Nature Communications · doi:10.1038/ncomms3583 · Cited by 44
Sun, H., Liu, L., Lü, J., Bai, L., Li, X., Nikolovska‐Coleska, Z., McEachern, D., Yang, C., Qiu, S., Han, Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101651b · Cited by 44
Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV‐134
Hashim, Y. M., Spitzer, D., Vangveravong, S., Hornick, M. C., Garg, G., Hornick, J. R., Goedegebuure, P. S., Mach, R. H., & Hawkins, W. G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.005 · Cited by 44
Silke, J., & Vince, J. E. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_507 · Cited by 46
Pan, W., Luo, Q., Yan, X., Yuan, L., Yi, H., Zhang, L., Li, B., Zhang, Y., Sun, J., Qiu, M., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.020 · Cited by 44
An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
Chang, Y.-C., & Cheung, C. H. A. (2020) · Applied Sciences · doi:10.3390/app11010335 · Cited by 48
“LCL161 and GDC‐0152 are pan‐IAP inhibitors that have similar affinities to XIAP, cIAP1, and cIAP2 [23,48,49,51].”
BackgroundStructural Basis for Bivalent Smac-Mimetics Recognition in the IAP Protein Family
Cossu, F., Milani, M., Mastrangelo, E., Vachette, P., Servida, F., Lecis, D., Canevari, G., Delia, D., Drago, C., Rizzo, V., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.033 · Cited by 44
Withanone as an inhibitor of survivin: A potential drug candidate for cancer therapy
Wadegaonkar, V. P., & Wadegaonkar, P. A. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.08.028 · Cited by 44
Csomos, R. A., Brady, G. F., & Duckett, C. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029983 · Cited by 44
Nonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins
Sun, H., Lü, J., Liu, L., Han, Y., Qiu, S., Yang, C., Deschamps, J. R., & Wang, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100487z · Cited by 44
“Benzyl (3S,6S,10aR)-6-((tert-butoxycarbonyl)amino)-5,9dioxodecahydropyrrolo[1,2-a]azocine-3-carboxylate (12) and benzyl (3S,6S, 10aR)-6-((tert-butoxycarbonyl)amino)-5,8-dioxodecahydropyrrolo[1,2a]azocine-3-carboxylate (13)—To a solution of the mixture of 10 and 11 obtained above (570 mg, 1.”
Non-lethal outcomes of engaging regulated cell death pathways in cancer
Kalkavan, H., Rühl, S., Shaw, J. J. P., & Green, D. R. (2023) · Nature Cancer · doi:10.1038/s43018-023-00571-6 · Cited by 48
Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death Switch
Puliyappadamba, V. T., Chakraborty, S., Chauncey, S. S., Li, L., Hatanpaa, K. J., Mickey, B., Noorani, S., Shu, H. G., Burma, S., Boothman, D. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.025 · Cited by 43
“RIP1 plays a key role in apoptotic cell death induced by stimuli such as TNFα, DNA damage, or cIAP inhibitors (Bertrand et al., 2008; Petersen et al., 2007; Varfolomeev et al., 2007; Vince et al., 2007).”
Gentle, I. E., Moelter, I., Lechler, N., Bambach, S. K., Vucikuja, S., Häcker, G. A., & Aichele, P. (2013) · Blood · doi:10.1182/blood-2013-01-479543 · Cited by 44
“Some cancer cells die in response to IAP antagonists due to autocrine TNF production as a result of NF-kB activation.(10,11,19) Some of these substances have entered clinical trials as cancer therapeutics.”
Schoeneberger, H., Belz, K., Schenk, B., & Fulda, S. (2014) · Oncogene · doi:10.1038/onc.2014.338 · Cited by 42
Li, S.-W., Lai, C., Ping, J.-F., Tsai, F., Wan, L., Lin, Y., Kung, S., & Lin, C. (2011) · Journal of General Virology · doi:10.1099/vir.0.028936-0 · Cited by 43
“NF-kB-inducing kinase, critical regulator of non-canonical NF-kB pathway, is ubiquitinated and degraded by RING finger E3 ligases (Varfolomeev et al., 2007).”
BackgroundMethodBerthelet, J., Wimmer, V. C., Whitfield, H. J., Serrano, A., Boudier, T., Mangiola, S., Merdas, M., El-Saafin, F., Baloyan, D., Wilcox, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf4408 · Cited by 44
TNF Receptor-Associated Factor (TRAF) Signaling Network in CD4+ T-Lymphocytes
So, T., Nagashima, H., & Ishii, N. (2015) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.236.139 · Cited by 48
Mastrangelo, E., Cossu, F., Milani, M., Sorrentino, G., Lecis, D., Delia, D., Manzoni, L., Drago, C., Seneci, P., Scolastico, C., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.064 · Cited by 43
BCL-XL regulates TNF-α-mediated cell death independently of NF-κB, FLIP and IAPs
Gozzelino, R., Solé, C., Llecha, N., Segura, M. F., Moubarak, R. S., Iglesias‐Guimarais, V., Pérez‐García, M. J., Reix, S., Zhang, J., Badiola, N., et al. (2008) · Cell Research · doi:10.1038/cr.2008.76 · Cited by 43
Identification of F ‐box only protein 7 as a negative regulator of NF ‐kappa B signalling
Kuiken, H. J., Egan, D. A., Laman, H., Bernards, R., Beijersbergen, R. L., & Dirac, A. M. G. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01524.x · Cited by 43
Cell death in hematological tumors
Fulda, S. (2009) · APOPTOSIS · doi:10.1007/s10495-008-0306-6 · Cited by 42
Guicciardi, M. E., Mott, J. L., Bronk, S. F., Kurita, S., Fingas, C. D., & Gores, G. J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.10.005 · Cited by 42
“cIAP-1 has been reported to undergo degradation via trafficking to lysosomes [26], or via a proteosomal-mediated pathway [16,27].”
InfluentialKupka, S., Reichert, M., Dráber, P., & Walczak, H. (2016) · FEBS Journal · doi:10.1111/febs.13644 · Cited by 41
A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling
Parvatiyar, K., Pindado, J., Dev, A., Aliyari, S. R., Zaver, S. A., Gerami, H., Chapon, M., Ghaffari, A. A., Dhingra, A., & Cheng, G. (2018) · Nature Communications · doi:10.1038/s41467-018-05168-7 · Cited by 43
Xiao, R., An, Y., Ye, W., Derakhshan, A., Cheng, H. W., Yang, X., Allen, C. T., Chen, Z., Schmitt, N. C., & Waes, C. V. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3802 · Cited by 42
Revving the CAR – Combination strategies to enhance CAR T cell effectiveness
Bansal, R., & Reshef, R. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100695 · Cited by 42
Yamamoto, M., Ito, T., Shimizu, T., Ishida, T., Semba, K., Watanabe, S., Yamaguchi, N., & Inoue, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01685.x · Cited by 41
Feltham, R., Moulin, M., Vince, J. E., Mace, P. D., Wong, W. W.-L., Anderton, H., Day, C. L., Vaux, D. L., & Silke, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087635 · Cited by 42
Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy
Zhang, X., Song, Z., Zhang, X., Zou, J., Yu, G., Chen, X. S., & Wang, S. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202507702 · Cited by 43
Liese, J., Abhari, B. A., & Fulda, S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.018 · Cited by 41
Cohen, F., Alicke, B., Elliott, L. O., Flygare, J. A., Goncharov, T., Keteltas, S. F., Franklin, M. C., Frankovitz, S. M., Stéphan, J.-P., Tsui, V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801450c · Cited by 41
Borghi, A., Haegman, M., Fischer, R., Carpentier, I., Bertrand, M. J. M., Libert, C., Afonina, I. S., & Beyaert, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.039 · Cited by 44
Zheng, M., Wu, Z., Wu, A., Huang, Z., He, N., & Xie, X. (2016) · Tumor Biology · doi:10.1007/s13277-015-4631-4 · Cited by 41
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation
Orth-He, E. L., Huang, H., Rao, S. D., Wang, Q., Chen, Q., O’Mara, C. M., Chui, A. J., Saoi, M., Griswold, A. R., Bhattacharjee, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111965 · Cited by 47
Meng, Q., Wei, K., & Shan, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433898 · Cited by 44
Lindemann, C., Marschall, V., Weigert, A., Klingebiel, T. E., & Fulda, S. (2015) · Neoplasia · doi:10.1016/j.neo.2015.05.002 · Cited by 39
SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma
Crawford, N., Stasik, I., Holohan, C., Majkut, J., McGrath, M., Johnston, P. G., Chessari, G., Ward, G. A., Waugh, D. J. J., Fennell, D. A., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.258 · Cited by 40
“SMCs also bind cIAP1 and cIAP2, resulting in a conformational change that leads to RING dimerization and activation of their E3 ligase activity, resulting in their rapid autoubiquitination and degradation.(23,24) As ligation of TNFR1 by TNFa in the absence of cIAP1 and cIAP2 rapidly leads to formation of the cell deat…”
The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress
Marivin, A., Berthelet, J., Plenchette, S., & Dubrez, L. (2012) · Cells · doi:10.3390/cells1040711 · Cited by 42
Fu, J., & Taubman, M. B. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00273-13 · Cited by 40
“Smac mimetic has been shown to trigger autodegradation of cIAP1 and cIAP2 (27, 46, 47).”
BackgroundWang, P., Teng, S., Chengyu, Z., Cui, Z. G., Ma, C., Yu, Y., Lei, Z., Min, M., Zongyi, W., Yang, M., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.017 · Cited by 42
Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
Lou, J., Zhou, Y., Feng, Z., Ma, M., Yao, Y., Wang, Y., Deng, Y., & Wu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.616952 · Cited by 39
“Besides, the second mitochondria-derived activator of caspase (SMAC) mimetics can representatively cause the auto-degradation of cIAPs (49).”
Cartier, J., Berthelet, J., Marivin, A., Gemble, S., Edmond, V., Plenchette, S., Lagrange, B., Hammann, A., Dupoux, A., Delva, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191239 · Cited by 48
Characterization of the Ripoptosome and Its Components
Schilling, R., Geserick, P., & Leverkus, M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801430-1.00004-4 · Cited by 38
Kang, T., Jeong, J.-S., Yang, S., Kovalenko, A., & Wallach, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0104-9 · Cited by 39
“RIPK1 phosphorylation was stimulated in the MEFs by their treatment for 3 h with TNF (1000 U/ml), together with the bivalent IAP (inhibitor of apoptosis protein) antagonist BV6 [51] and the caspase inhibitor z-VAD-fmk (both from WuXi AppTec) at concentrations of 1 and 20 μM, respectively.”
Orvedahl, A., McAllaster, M. R., Sansone, A., Dunlap, B. F., Desai, C., Wang, Y., Balce, D. R., Luke, C. J., Lee, S., Orchard, R. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1822157116 · Cited by 40
Bongiorno, R., Colombo, M. P., & Lecis, D. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02192-2 · Cited by 44
“NIK is usually degraded in a continuous fashion by cIAP1 and cIAP2 [58] in order to block the activation of its downstream pathway, but mutations or silencing of UPF1 were shown to aberrantly cause the accumulation of NIK resulting in chemokine production and massive immune infiltration in lung IMT [56].”
BackgroundYoon, S., Bogdanov, K., & Wallach, D. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-021-00924-7 · Cited by 40
Häcker, G. A., & Haimovici, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01058-0 · Cited by 42
Sun, H., Lü, J., Liu, L., Yang, C., & Wang, S. (2014) · ACS Chemical Biology · doi:10.1021/cb400889a · Cited by 40
Sun, W. D., Nikolovska‐Coleska, Z., Qin, D., Sun, H., Yang, C., Bai, L., Qiu, S., Wang, Y., Ma, D., & Wang, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801101z · Cited by 39
Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy
Owens, T. W. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s14-004 · Cited by 38
Pathophysiological Significance of Hepatic Apoptosis
Wang, K., & Lin, B. (2012) · ISRN Hepatology · doi:10.1155/2013/740149 · Cited by 39
Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma
Cormier, F., Monjanel, H., Fabre, C., Billot, K., Sapharikas, E., Chéreau, F., Bordereaux, D., Molina, T. J., Avet‐Loiseau, H., & Baud, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059127 · Cited by 42
Dufour, F., Bertrand, L., Pearson, A., Grandvaux, N., & Langelier, Y. (2011) · Journal of Virology · doi:10.1128/jvi.00362-11 · Cited by 38
SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib
Ohoka, N., Nagai, K., Shibata, N., Hattori, T., Nara, H., Cho, N., & Naito, M. (2017) · Cancer Science · doi:10.1111/cas.13198 · Cited by 39
Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
Liu, J., Peng, Y., & Wei, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.678077 · Cited by 38
Shi, S., Verstegen, M. M. A., Roest, H. P., Ardisasmita, A. I., Cao, W., Roos, F. J. M., de Ruiter, P. E., Niemeijer, M., Pan, Q., IJzermans, J. N. M., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.10.009 · Cited by 38
“In contrast, apoptosis involves activation of the noncanonical NF-kB pathway induced by TNF-a and Smac mimetic signaling.(27) We reasoned that distinct activation of NF-kB signaling might be observed in apoptotic and necroptotic hICOs.”
BackgroundSong, E. Z., Wang, X., Philipson, B. I., Zhang, Q., Thokala, R., Zhang, L., Assenmacher, C., Binder, Z. A., Ming, G., O’Rourke, D. M., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.11.004 · Cited by 41
Litopenaeus vannamei inhibitor of apoptosis protein 1 (LvIAP1) is essential for shrimp survival
Leu, J., Chen, Y., Chen, L.-L., Chen, K.-Y., Huang, H., Ho, J.-M., & Lo, C. (2012) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.04.006 · Cited by 38
“, 1995) and play important roles in TNFmediated induction of NF-jB signaling (Petersen et al., 2007; Varfolomeev et al., 2007).”
BackgroundTargeting Apoptosis Signaling Pathways for Anticancer Therapy
Fulda, S. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00023 · Cited by 38
“…engage cell death pathways by initiating autoubiquitination of cIAPs leading to activation of non-canonical NF-κB and TNFα-mediated apoptosis (Petersen et al., 2007; Varfolomeev et al., 2007; Vince et al., 2007). www.frontiersin.org August 2011 | Volume 1 | Article 23 | 5 and Ashkenazi, A. (2001).”
Cyclopeptide Smac mimetics as antagonists of IAP proteins
Sun, H., Liu, L., Lü, J., Qiu, S., Yang, C., Han, Y., & Wang, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.114 · Cited by 42
Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death
Hui, K. K., Kanungo, A., Elia, A., & Henderson, J. T. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.50 · Cited by 38
The structure of XIAP BIR2: understanding the selectivity of the BIR domains
Lukacs, C., Belunis, C. J., Crowther, R. L., Danho, W., Gao, L., Goggin, B. S., Janson, C. A., Li, S., Remiszewski, S., Schutt, A. D., et al. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913016284 · Cited by 40
“Smac is a dimer in solution, and it can bind both the BIR2 and BIR3 domains of XIAP simultaneously to prevent XIAP from binding and inhibiting caspase-3, caspase-7 and caspase-9 (Du et al., 2000; Varfolomeev et al., 2007).”
Role of Smac in Determining the Chemotherapeutic Response of Esophageal Squamous Cell Carcinoma
Yang, X., Zhou, L., Huang, J., Liu, F., Yu, J., Zhan, Q., Zhang, L., & Zhao, X. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0426 · Cited by 38
Fueling the Flames: Mammalian Programmed Necrosis in Inflammatory DiseasesPreprint
Chan, F. K.-M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008805 · Cited by 37
“This explains why Smac mimetics or IAP antagonists, which target cIAP-1, cIAP-2, and XIAP for autoubiquitination and degradation to promote assembly of the ripoptosome (Petersen et al. 2007; Varfolomeev et al. 2007; Vince et al. 2007; Bertrand et al. 2008), can further enhance TNFinduced necrosis.”
BackgroundHow do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?
Schröfelbauer, B., & Hoffmann, A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01060.x · Cited by 37
Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 Is Linked to TNF-α Pharmacology
Erickson, R. I., Tarrant, J. M., Cain, G. R., Lewin-Koh, S.-C., Dybdal, N. O., Wong, H., Blackwood, E. R., West, K. A., Steigerwalt, R. W., Mamounas, M. J., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs265 · Cited by 38
“Monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor alpha (TNF-α) are among the expressed chemokines and cytokines, the latter being most important for single-agent cellkilling activity (Varfolomeev et al., 2007; Vince et al., 2007).”
BackgroundKnights, A. J., Fucikova, J. P., Pasam, A., Koernig, S., & Cebon, J. S. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1342-1 · Cited by 37
“accumulation of NIK and activation of the alternative NFjB pathways in other cell types [9, 10], and indeed, we observed concurrent activation of NF-jB signaling in moDC following treatment with LCL161, a transient loss and then recovery of cIAP2 and further upregulation of anti-apoptotic molecules.”
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
Shekhar, T. M., Burvenich, I. J. G., Harris, M. A., Rigopoulos, A., Zanker, D. J., Spurling, A., Parker, B. S., Walkley, C. R., Scott, A. M., & Hawkins, C. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-6103-5 · Cited by 37
SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages
Campbell, G. R., To, R. K., Zhang, G., & Spector, S. A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02761-x · Cited by 37
Targeting the Ubiquitin System in Glioblastoma
Scholz, N., Kurian, K. M., Siebzehnrübl, F. A., & Licchesi, J. D. F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.574011 · Cited by 37
Hu, X., Zimmerman, M. A., Bardhan, K., Yang, D., Waller, J. L., Liles, G. B., Lee, J. R., Pollock, R. E., Lev, D. C., Ware, C. F., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt014 · Cited by 37
Zhang, B., Nikolovska‐Coleska, Z., Zhang, Y., Bai, L., Qiu, S., Yang, C., Sun, H., Wang, S., & Wu, Y. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801146d · Cited by 37
Mosadegh, M., Goodarzi, N. N., & Erfani, Y. (2025) · Cancer Investigation · doi:10.1080/07357907.2024.2445528 · Cited by 47
Bornstein, B., Gottfried, Y., Edison, N., Shekhtman, A., Lev, T., Glaser, F., & Larisch, S. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0622-0 · Cited by 36
Van, D. N., Roberts, C. F., Marion, J. D., Lépine, S., Harikumar, K. B., Schreiter, J., Dumur, C. I., Fang, X., Spiegel, S., & Bell, J. K. (2012) · The FASEB Journal · doi:10.1096/fj.11-202333 · Cited by 36
“When DOV-13 and SKOV-3 cells were treated with a SMAC mimetic to induce c-IAP2 proteasomal degradation (31), cell death increased in SKOV-3 cells, but pI:pC stimulation did not further augment cell death (Fig.”
BackgroundElimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies
Xiao, H., Jensen, P. E., & Chen, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184360 · Cited by 36
Lu, X., Sabbasani, V. R., Amponsa, V. O., Evans, C. N., King, J. C., Tarasov, S. G., Dyba, M., Das, S., Chan, K. C., Schwieters, C. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27570-4 · Cited by 35
Huang, J.-L., Yan, X., Li, W., Fan, R., Li, S., Chen, J., Zhang, Z., Sang, J., Gan, L., Tang, G., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c06449 · Cited by 39
Targeting Inhibitor of Apoptosis Proteins for Therapeutic Intervention
Ndubaku, C. O., Cohen, F., Varfolomeev, E. E., & Vucic, D. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.116 · Cited by 36
Zhang, L., Blackwell, K., Thomas, G. S., Sun, S., Yeh, W., & Habelhah, H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.054 · Cited by 36
Sheng, R., Sun, H., Liu, L., Lü, J., McEachern, D., Wang, G., Wen, J., Min, P., Du, Z., Lu, H., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400216d · Cited by 36
Metadata
- Authors
- Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., Flygare, J. A., Fairbrother, W. J., Deshayes, K., Dixit, V. M., & Vucic, D.
- Affiliations
- Genentech (US)
- Corresponding author
- Dixit, Vishva M.
- Vucic, Domagoj
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 131
- Issue
- 4
- Pages
- 669-681
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2064299413
- Cited by
- 1,218
- References
- 51
- Citations by year
- 2026: 28 · 2025: 24 · 2024: 39 · 2023: 45 · 2022: 41 · 2021: 60 · 2020: 59 · 2019: 54 · 2018: 69 · 2017: 64 · 2016: 78 · 2015: 80 · 2014: 100 · 2013: 78 · 2012: 71
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- inhibitor of apoptosis proteins, IAP antagonists, cIAP1, cIAP2, autoubiquitination, proteasomal degradation, NF-κB signaling, non-canonical NF-κB signaling, NIK, TNF signaling, apoptosis, cancer therapeutics
- MeSH terms
- Animals, Cell Line, Humans, Neoplasms, Tumor Necrosis Factor-alpha, Molecular Structure, Signal Transduction, NF-kappa B, Apoptosis, Protein Structure, Tertiary, Polyubiquitin, Proteasome Endopeptidase Complex, Inhibitor of Apoptosis Proteins, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review